Companies take diverse approaches to aligning supply with demand
The 2017 Access to Vaccines Index evaluated the approaches taken by six companies in aligning vaccine supply with global demand. All six companies implement a combination of the elements assessed. No particular combination is identified as best practice, but implementing more elements is expected to better prevent shortages. Each company's approach is likely to be linked to its portfolio, structure and business model. The six companies evaluated were: GSK, Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi and Serum Institute of India.